Post-Portfolio

Post-Portfolio refers to the clinical development phase of a drug discovery project that follows candidate selection. Once a compound has progressed through H2L, LO, and SP, it enters the post-portfolio phase, which includes: IND (Investigational New Drug application) and P1 (Phase 1 clinical trial)

📄️ Post-Portfolio Module Structure

The Post-Portfolio module in DAIKON is organized into two tabs, identical to the Portfolio section:

📄️ Post Portfolio Detailed View

The Post-Portfolio Detail View offers a deep dive into each clinical-stage project (IND or P1).

📄️ Create a Post Portfolio

To create a new post-portfolio: